1. Home
  2. AMPH vs CTS Comparison

AMPH vs CTS Comparison

Compare AMPH & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • CTS
  • Stock Information
  • Founded
  • AMPH 1996
  • CTS 1896
  • Country
  • AMPH United States
  • CTS United States
  • Employees
  • AMPH N/A
  • CTS N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • CTS Electrical Products
  • Sector
  • AMPH Health Care
  • CTS Technology
  • Exchange
  • AMPH Nasdaq
  • CTS Nasdaq
  • Market Cap
  • AMPH 1.2B
  • CTS 1.2B
  • IPO Year
  • AMPH 2014
  • CTS N/A
  • Fundamental
  • Price
  • AMPH $24.39
  • CTS $42.07
  • Analyst Decision
  • AMPH Buy
  • CTS
  • Analyst Count
  • AMPH 6
  • CTS 0
  • Target Price
  • AMPH $35.50
  • CTS N/A
  • AVG Volume (30 Days)
  • AMPH 369.0K
  • CTS 212.2K
  • Earning Date
  • AMPH 11-06-2025
  • CTS 10-28-2025
  • Dividend Yield
  • AMPH N/A
  • CTS 0.38%
  • EPS Growth
  • AMPH N/A
  • CTS 18.55
  • EPS
  • AMPH 2.68
  • CTS 2.11
  • Revenue
  • AMPH $722,679,000.00
  • CTS $520,937,000.00
  • Revenue This Year
  • AMPH $1.00
  • CTS $3.90
  • Revenue Next Year
  • AMPH $6.74
  • CTS $6.50
  • P/E Ratio
  • AMPH $9.15
  • CTS $19.97
  • Revenue Growth
  • AMPH 1.37
  • CTS 1.12
  • 52 Week Low
  • AMPH $20.39
  • CTS $34.02
  • 52 Week High
  • AMPH $53.96
  • CTS $59.68
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 40.87
  • CTS 58.97
  • Support Level
  • AMPH $22.94
  • CTS $40.81
  • Resistance Level
  • AMPH $24.87
  • CTS $41.50
  • Average True Range (ATR)
  • AMPH 0.79
  • CTS 1.33
  • MACD
  • AMPH 0.12
  • CTS 0.46
  • Stochastic Oscillator
  • AMPH 42.90
  • CTS 86.67

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

Share on Social Networks: